PTGS2 and cancer: On the one hand, there was strong experimental and epidemiological evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase 2 (COX-2) inhibitors might have a potential as cancer chemopreventive agents [29].